These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 2591259)
21. Glycosylated haemoglobin in the diagnosis of diabetes mellitus in elderly people. Mulkerrin EC; Arnold JD; Dewar R; Sykes D; Rees A; Pathy MS Age Ageing; 1992 May; 21(3):175-7. PubMed ID: 1615778 [TBL] [Abstract][Full Text] [Related]
22. Insufficient sensitivity of hemoglobin A(₁C) determination in diagnosis or screening of early diabetic states. Fajans SS; Herman WH; Oral EA Metabolism; 2011 Jan; 60(1):86-91. PubMed ID: 20723948 [TBL] [Abstract][Full Text] [Related]
23. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose? Yu EY; Wong CK; Ho SY; Wong SY; Lam CL Fam Pract; 2015 Dec; 32(6):631-8. PubMed ID: 26467644 [TBL] [Abstract][Full Text] [Related]
24. [Diagnostic criteria for diabetes mellitus]. Tominaga M Rinsho Byori; 1999 Oct; 47(10):901-8. PubMed ID: 10590663 [TBL] [Abstract][Full Text] [Related]
25. An assessment of the new NIH diagnostic criteria for diabetes mellitus according to insulin response in a 75 g oral glucose tolerance test and levels of hemoglobin AIC. Kanatsuka A; Osegawa M; Makino H; Kanzaki T; Hashimoto N; Kumagai A Horm Metab Res; 1982 Dec; 14(12):626-30. PubMed ID: 6759357 [TBL] [Abstract][Full Text] [Related]
26. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus. Mula-Abed WA; Al-Naemi AH Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621 [TBL] [Abstract][Full Text] [Related]
27. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV. Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342 [TBL] [Abstract][Full Text] [Related]
28. Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography. Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Lee WL; Liang KW; Sheu WH Clin Chem Lab Med; 2015 Aug; 53(9):1441-9. PubMed ID: 25405720 [TBL] [Abstract][Full Text] [Related]
29. Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening. Little RR; England JD; Wiedmeyer HM; McKenzie EM; Pettitt DJ; Knowler WC; Goldstein DE Diabetes; 1988 Jan; 37(1):60-4. PubMed ID: 3335278 [TBL] [Abstract][Full Text] [Related]
30. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation. Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438 [TBL] [Abstract][Full Text] [Related]
31. Influence of the glycation gap on the diagnosis of type 2 diabetes. Rodriguez-Segade S; Rodriguez J; García-López JM; Casanueva FF; Coleman IC; Alonso de la Peña C; Camiña F Acta Diabetol; 2015 Jun; 52(3):453-9. PubMed ID: 25344767 [TBL] [Abstract][Full Text] [Related]
32. Is examination of fructosamine levels valuable as a diagnostic test for diabetes mellitus? Sekikawa A; Tominaga M; Takahashi K; Watanabe H; Miyazawa K; Sasaki H Diabetes Res Clin Pract; 1990 Mar; 8(3):187-92. PubMed ID: 2340792 [TBL] [Abstract][Full Text] [Related]
33. [Glycosylated hemoglobin in the diagnosis of diabetes mellitus]. Tian H; Lian J; Zhang X Hua Xi Yi Ke Da Xue Xue Bao; 1990 Jun; 21(2):197-200. PubMed ID: 2391104 [TBL] [Abstract][Full Text] [Related]
34. Statistical Analysis on Threshold of Haemoglobin A1C (HBA1c) for Diabetes Diagnosis and the Relationship Between HBA1c and Plasma Glucose Concentrations in Chinese Diabetic High-Risk Groups. Li X; Bao C; Zhao Y; Song H; Wang W Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868839 [TBL] [Abstract][Full Text] [Related]
36. Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus. Eide IA; Halden TA; Hartmann A; Åsberg A; Dahle DO; Reisæter AV; Jenssen T Transplantation; 2015 Mar; 99(3):629-35. PubMed ID: 25162478 [TBL] [Abstract][Full Text] [Related]
37. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening. Adam JM; Tarigan NP Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695 [TBL] [Abstract][Full Text] [Related]
38. [Glycosylated hemoglobins and the oral glucose tolerance test in evaluation of glucose tolerance]. Seghieri G; De Giorgio LA; Gironi A; Innocenti F; Pettinà G Quad Sclavo Diagn; 1981 Mar; 17(1):73-80. PubMed ID: 7313072 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India. Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281 [TBL] [Abstract][Full Text] [Related]
40. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening. Jesudason DR; Dunstan K; Leong D; Wittert GA Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]